| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Akso Health Group Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.67 |
| 52 Week High | US$2.54 |
| 52 Week Low | US$0.19 |
| Beta | 0.16 |
| 11 Month Change | -35.58% |
| 3 Month Change | -36.19% |
| 1 Year Change | 142.75% |
| 33 Year Change | -48.46% |
| 5 Year Change | -89.76% |
| Change since IPO | -97.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8HX | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -5.6% | -1.5% | 0.09% |
| 1Y | 142.8% | 0.8% | 3.1% |
Return vs Industry: 8HX exceeded the German Healthcare industry which returned 0.7% over the past year.
Return vs Market: 8HX exceeded the German Market which returned 3% over the past year.
Price Volatility
| 8HX volatility | |
|---|---|
| 8HX Average Weekly Movement | 18.9% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 8HX's share price has been volatile over the past 3 months.
Volatility Over Time: 8HX's weekly volatility has decreased from 25% to 19% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 12 | Linda Wang | www.xiaobaimaimai.com |
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products.
Akso Health Group Fundamentals Summary
| 8HX fundamental statistics | |
|---|---|
| Market cap | €103.89m |
| Earnings (TTM) | -€16.72m |
| Revenue (TTM) | €2.07m |
50.5x
P/S Ratio-6.3x
P/E RatioIs 8HX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8HX income statement (TTM) | |
|---|---|
| Revenue | US$2.22m |
| Cost of Revenue | US$2.04m |
| Gross Profit | US$181.94k |
| Other Expenses | US$18.07m |
| Earnings | -US$17.89m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 8.20% |
| Net Profit Margin | -806.63% |
| Debt/Equity Ratio | 188.2% |
How did 8HX perform over the long term?
See historical performance and comparison